The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers

AIMS: Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT(1B/1D) receptor agonist developed for the acute oral treatment of migraine. A highly sensitive LCMS-MS assay has been developed which allows quantification of plasma concentrations of zolmitriptan and its active metabolite, 183C91, after t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Seaber, Emma J, Peck, Richard W, Smith, Deborah A, Allanson, John, Hefting, Nanco R, van Lier, Jan J, Sollie, Frans A E, Wemer, Johan, Jonkman, Jan H G
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 1998
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1873688/
https://ncbi.nlm.nih.gov/pubmed/9833595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1998.00809.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires